CRONOS GROUP INC. Financing Cash Flow
CRONOS GROUP INC. (CRON) reported Financing Cash Flow of -$39.15 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- CRONOS GROUP INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$20.88M.
- CRONOS GROUP INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$18.27M.
- CRONOS GROUP INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$7.42M.
- CRONOS GROUP INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$1.87M.
- CRONOS GROUP INC. net cash provided by (used in) financing activities for fiscal 2025 was -$19.91M.
- CRONOS GROUP INC. net cash provided by (used in) financing activities for fiscal 2024 was -$1.23M.
- CRONOS GROUP INC. net cash provided by (used in) financing activities for fiscal 2023 was -$1.03M.
- CRONOS GROUP INC. net cash provided by (used in) financing activities for fiscal 2022 was -$2.90M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$20.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$39.15M 10-Q · filed 2026-08-06 | -$46.57M derived: sum of 3 quarters · filed 2026-08-06 | -$48.44M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$18.27M 10-Q · filed 2026-05-11 | -$25.69M derived: sum of 2 quarters · filed 2026-05-11 | -$27.56M derived: sum of 3 quarters · filed 2026-05-11 | -$35.24M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$7.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$9.29M derived: sum of 2 quarters · filed 2026-02-26 | -$16.98M derived: sum of 3 quarters · filed 2026-08-06 | -$19.91M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | -$1.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$9.55M derived: sum of 2 quarters · filed 2026-08-06 | -$12.48M 10-Q · filed 2025-11-06 | -$12.79M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$7.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$10.62M 10-Q · filed 2026-08-06 | -$10.93M derived: sum of 3 quarters · filed 2026-08-06 | -$10.94M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$2.93M 10-Q · filed 2026-05-11 | -$3.24M derived: sum of 2 quarters · filed 2026-05-11 | -$3.26M derived: sum of 3 quarters · filed 2026-05-11 | -$3.52M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | -$313.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$326.00K derived: sum of 2 quarters · filed 2026-02-26 | -$586.00K derived: sum of 3 quarters · filed 2026-02-26 | -$1.23M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | -$13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$273.00K derived: sum of 2 quarters · filed 2025-11-06 | -$918.00K 10-Q · filed 2025-11-06 | -$1.14M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | -$260.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$905.00K 10-Q · filed 2025-08-07 | -$1.12M derived: sum of 3 quarters · filed 2026-02-26 | -$1.15M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | -$645.00K 10-Q · filed 2025-05-08 | -$863.00K derived: sum of 2 quarters · filed 2026-02-26 | -$893.00K derived: sum of 3 quarters · filed 2026-02-26 | -$932.00K derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | -$218.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$248.00K derived: sum of 2 quarters · filed 2026-02-26 | -$287.00K derived: sum of 3 quarters · filed 2026-02-26 | -$1.03M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | -$30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$69.00K derived: sum of 2 quarters · filed 2024-11-12 | -$812.00K 10-Q · filed 2024-11-12 | -$1.43M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-06-30 | -$39.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$782.00K 10-Q · filed 2024-08-08 | -$1.40M derived: sum of 3 quarters · filed 2025-02-27 | -$1.65M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-03-31 | -$743.00K 10-Q · filed 2024-05-09 | -$1.36M derived: sum of 2 quarters · filed 2025-02-27 | -$1.61M derived: sum of 3 quarters · filed 2025-02-27 | -$3.18M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2022-12-31 | -$620.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$863.00K derived: sum of 2 quarters · filed 2025-02-27 | -$2.43M derived: sum of 3 quarters · filed 2025-02-27 | -$2.90M 10-K · filed 2025-02-27 | ||||
| 2022-09-30 | -$243.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$1.81M derived: sum of 2 quarters · filed 2023-11-08 | -$2.28M 10-Q · filed 2023-11-08 | -$2.56M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-06-30 | -$1.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$2.03M 10-Q · filed 2023-08-08 | -$2.31M derived: sum of 3 quarters · filed 2024-02-29 | -$6.57M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-03-31 | -$464.00K 10-Q · filed 2023-05-09 | -$742.00K derived: sum of 2 quarters · filed 2024-02-29 | -$5.00M derived: sum of 3 quarters · filed 2024-02-29 | -$5.24M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | -$278.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$4.54M derived: sum of 2 quarters · filed 2024-02-29 | -$4.78M derived: sum of 3 quarters · filed 2024-02-29 | -$13.44M 10-K · filed 2024-02-29 | ||||
| 2021-09-30 | -$4.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$4.50M derived: sum of 2 quarters · filed 2022-11-07 | -$13.16M 10-Q · filed 2022-11-07 | -$13.88M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | -$244.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$8.91M 10-Q · filed 2022-08-09 | -$9.63M derived: sum of 3 quarters · filed 2023-02-28 | -$11.96M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | -$8.66M 10-Q · filed 2022-05-10 | -$9.28M 10-Q · filed 2021-05-07 | -$9.38M derived: sum of 2 quarters · filed 2023-02-28 | -$11.71M derived: sum of 3 quarters · filed 2023-02-28 | -$11.27M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2020-12-31 | -$721.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$3.05M derived: sum of 2 quarters · filed 2023-02-28 | -$2.60M derived: sum of 3 quarters · filed 2023-02-28 | -$3.05M 10-K · filed 2023-02-28 | -$5.46M 10-K · filed 2021-02-26 | |||
| 2020-09-30 | -$2.33M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-02-18 | -$1.88M derived: sum of 2 quarters · filed 2022-02-18 | -$2.33M 10-Q · filed 2022-02-18 | -$4.19M 10-Q · filed 2020-11-05 | $33.33M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-06-30 | $449.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2022-02-18 | $1.00K 10-Q/A · filed 2022-02-18 | -$1.18M 10-Q · filed 2020-08-06 | $35.66M derived: sum of 3 quarters · filed 2022-03-01 | $66.43M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-03-31 | -$448.00K 10-Q · filed 2021-05-07 | $35.21M derived: sum of 2 quarters · filed 2022-03-01 | $65.98M derived: sum of 3 quarters · filed 2022-03-01 | $66.21M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $35.66M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $66.43M derived: sum of 2 quarters · filed 2022-03-01 | $66.66M derived: sum of 3 quarters · filed 2022-03-01 | $1.86B 10-K · filed 2022-03-01 | $1.86B 10-K/A · filed 2020-03-30 | |||
| 2019-09-30 | $30.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $30.99M derived: sum of 2 quarters · filed 2020-11-05 | $1.82B 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | $227.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $1.79B 10-Q · filed 2020-08-06 | ||||||
| 2019-03-31 | $1.79B 10-Q · filed 2020-05-08 | |||||||
| 2018-12-31 | $122.11M 10-K · filed 2021-02-26 | |||||||
| 2017-12-31 | $39.07M 10-K/A · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |